A systematic review and meta-analysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases

HPB

Volumn 19, Issue 6, 2017, Pages 491-497

  Wurster, Elena F ^a   Tenckhoff, Solveig ^a   Probst, Pascal ^a   Jensen, Katrin ^a   Dölger, Eva ^a   Knebel, Phillip ^a   Diener, Markus K ^a   Büchler, Markus W ^a   Ulrich, Alexis ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE LEAKAGE; CLINICAL STUDY; COLORECTAL CANCER; FISTULA; HUMAN; INTERMETHOD COMPARISON; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; META ANALYSIS; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; REVIEW; SAFETY; SURVIVAL RATE; SYSTEMATIC REVIEW; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; KAPLAN MEIER METHOD; LIVER TUMOR; METASTASIS RESECTION; ODDS RATIO; PATHOLOGY; PROCEDURES; REOPERATION; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; METASTASECTOMY; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; REOPERATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85017098655     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1016/j.hpb.2017.02.440     Document Type: Review

References (38)

1. Kanas, G.P., Taylor, A., Primrose, J.N., Langeberg, W.J., Kelsh, M.A., Mowat, F.S., et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4 (2012), 283–301.
2. Tjandra, J.J., Chan, M.K., Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum 50 (2007), 1783–1799.
3. Hasegawa, Y., Nitta, H., Sasaki, A., Takahara, T., Itabashi, H., Katagiri, H., et al. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: a comparative analysis of 168 consecutive cases at a single center. Surgery 157 (2015 Jun), 1065–1072.
4. Kuo, I.M., Huang, S.F., Chiang, J.M., Yeh, C.Y., Chan, K.M., Chen, J.S., et al. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis. World J Surg Oncol, 13, 2015 Mar 4, 92.
5. Griffith, K.D., Sugarbaker, P.H., Chang, A.E., Repeat hepatic resections for colorectal metastases. Surgery 107 (1990), 101–104.
6. Antoniou, A., Lovegrove, R.E., Tilney, H.S., Heriot, A.G., John, T.G., Rees, M., et al. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases. Surgery 141 (2007), 9–18.
7. Luo, L.X., Yu, Z.Y., Huang, J.W., Wu, H., Selecting patients for a second hepatectomy for colorectal metastases: an systemic review and meta-analysis. Eur J Surg Oncol 40 (2014 Sep), 1036–1048.
8. Yan, T.D., Sim, J., Black, D., Niu, R., Morris, D.L., Systematic review on safety and efficacy of repeat hepatectomy for recurrent liver metastases from colorectal carcinoma. Ann Surg Oncol 14 (2007 Jul), 2069–2077.
9. Lam, V.W., Pang, T., Laurence, J.M., Johnston, E., Hollands, M.J., Pleass, H.C., et al. A systematic review of repeat hepatectomy for recurrent colorectal liver metastases. J Gastrointest Surg 17 (2013 Jul), 1312–1321.
10. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8 (2010), 336–341.
11. Downs, S.N., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52 (1998), 377–384.
12. Hozo, S.P., Djulbegovic, B., Hozo, I., Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol, 5, 2005, 13.
13. Parmar, M.K., Torri, V., Stewart, L., Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17 (1998), 2815–2834.
14. Tierney, J.F., Stewart, L.A., Ghersi, D., Burdett, S., Sydes, M.R., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 2007, 16.
15. Adam, R., Pascal, G., Azoulay, D., Tanaka, K., Castaing, D., Bismuth, H., Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238 (2003), 871–883 discussion 883–4.
16. Ahmad, A., Chen, S.L., Bilchik, A.J., Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg 142 (2007), 526–531 discussion 531–2.
17. Battula, N., Tsapralis, D., Mayer, D., Isaac, J., Muiesan, P., Sutcliffe, R.P., et al. Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience. HPB 16 (2014 Feb), 157–163.
18. Sa Cunha, A., Laurent, C., Rault, A., Couderc, P., Rullier, E., Saric, J., A second liver resection due to recurrent colorectal liver metastases. Arch Surg 142 (2007 Dec), 1144–1149 discussion 1150.
19. Saiura, A., Yamamoto, J., Koga, R., Takahashi, Y., Takahashi, M., Inoue, Y., et al. Favorable outcome after repeat resection for colorectal liver metastases. Ann Surg Oncol 21 (2014 Dec), 4293–4299.
20. Shaw, I.M., Rees, M., Welsh, F.K., Bygrave, S., John, T.G., Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 93 (2006 Apr), 457–464.
21. von Heesen, M., Schuld, J., Sperling, J., Grunhage, F., Lammert, F., Richter, S., et al. Parenchyma-preserving hepatic resection for colorectal liver metastases. Langenbecks Arch Surg 397 (2012 Mar), 383–395.
22. Yamazaki, S., Takayama, T., Okada, S., Iwama, A., Midorikawa, Y., Moriguchi, M., et al. Good candidates for a third liver resection of colorectal metastasis. World J Surg 37 (2013 Apr), 847–853.
23. Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O.A., Bero, L., Industry sponsorship and research outcome. Cochrane Database Syst Rev, 12, 2012 MR000033.
24. Probst, P., Knebel, P., Grummich, K., Tenckhoff, S., Ulrich, A., Büchler, M.W., et al. Industry bias in randomized controlled trials in general and abdominal surgery: an empirical study. Ann Surg 264 (2016 Jul), 87–92.
25. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
26. Scorsetti, M., Comito, T., Tozzi, A., Navarria, P., Fogliata, A., Clerici, E., et al. Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer. J Cancer Res Clin Oncol 141 (2015), 543–553.
27. Gruber-Rouh, T., Naguib, N.N., Eichler, K., Ackermann, H., Zangos, S., Trojan, J., et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer 134 (2014), 1225–1231.
28. Gallagher, D.J., Kemeny, N., Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78 (2010), 237–248.
29. Wei, A.C., Greig, P.D., Grant, D., Taylor, B., Langer, B., Gallinger, S., Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13 (2006), 668–676.
30. Gujral, S., Avery, K.N., Blazeby, J.M., Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials. Support Care Cancer 16 (2008), 127–132.
31. Jansen, L., Koch, L., Brenner, H., Arndt, V., Quality of life among long-term (≥5 years) colorectal cancer survivors–systematic review. Eur J Cancer 46 (2010), 2879–2888.
32. Deimling, G.T., Sterns, S., Bowman, K.F., Kahana, B., The health of older-adult, long-term cancer survivors. Cancer Nurs 28 (2005), 415–424.
33. Stommel, M., Kurtz, M.E., Kurtz, J.C., Given, C.W., Given, B.A., A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol 23 (2004), 564–573.
34. Primrose, J., Falk, S., Finch-Jones, M., Valle, J., O'Reilly, D., Siriwardena, A., et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. Lancet Oncol 15 (2014), 601–611.
35. Gruenberger, B., Tamandl, D., Schueller, J., Scheithauer, W., Zielinski, C., Herbst, F., et al. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26 (2008), 1830–1835.
36. Ji, J.H., Park, S.H., Lee, J., Kim, T.W., Hong, Y.S., Kim, K.P., et al. Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis. Cancer Chemother Pharmacol 72 (2013), 223–230.
37. http://www.eortc.org/investigators/quality-assurance/climb-1409/, July 26th, 2016.
38. West, S.G., Duan, N., Pequegnat, W., Gaist, P., Des Jarlais, D.C., Holtgrave, D., et al. Alternatives to the randomized controlled trial. Am J Public Health 98 (2008), 1359–1366.